Classification of childhood white matter disorders using proton MR spectroscopic imaging

Alberto Bizzi, G. Castelli, M. Bugiani, P. B. Barker, E. H. Herskovits, U. Danesi, A. Erbetta, I. Moroni, L. Farina, G. Uziel

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Childhood white matter disorders often show similar MR imaging signal-intensity changes, despite different underlying pathophysiologies. The purpose of this study was to determine if proton MR spectroscopic imaging (1H-MRSI) may help identify tissue pathophysiology in patients with leukoencephalopathies. MATERIALS AND METHODS: Seventy patients (mean age, 6; range, 0.66-17 years) were prospectively examined by 1H-MRSI; a diagnosis of leukoencephalopathy due to known genetic defects leading to lack of formation, breakdown of myelin, or loss of white matter tissue attenuation (rarefaction) was made in 47 patients. The diagnosis remained undefined (UL) in 23 patients. Patients with definite diagnoses were assigned (on the basis of known pathophysiology) to 3 groups corresponding to hypomyelination, white matter rarefaction, and demyelination. Choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) signals from 6 white matter regions and their intra- and intervoxel (relative to gray matter) ratios were measured. Analysis of variance was performed by diagnosis and by pathophysiology group. Stepwise linear discriminant analysis was performed to construct a model to predict pathophysiology on the basis of 1H-MRSI, and was applied to the UL group. RESULTS: Analysis of variance by diagnosis showed 3 main metabolic patterns. Analysis of variance by pathophysiology showed significant differences for Cho/NAA (P <.001), Cho/Cr (P <.004), and NAA/Cr (P <.002). Accuracy of the linear discriminant analysis model was 75%, with Cho/Cr and NAA/Cr being the best parameters for classification. On the basis of the linear discriminant analysis model, 61% of the subjects in the UL group were classified as hypomyelinating. CONCLUSION: 1H-MRSI provides information on tissue pathophysiology and may, therefore, be a valuable tool in the evaluation of patients with leukoencephalopathies.

Original languageEnglish
Pages (from-to)1270-1275
Number of pages6
JournalAmerican Journal of Neuroradiology
Volume29
Issue number7
DOIs
Publication statusPublished - Aug 2008

Fingerprint

Creatine
Protons
Leukoencephalopathies
Discriminant Analysis
Choline
Analysis of Variance
Demyelinating Diseases
Myelin Sheath
White Matter
N-acetylaspartate

ASJC Scopus subject areas

  • Clinical Neurology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Bizzi, A., Castelli, G., Bugiani, M., Barker, P. B., Herskovits, E. H., Danesi, U., ... Uziel, G. (2008). Classification of childhood white matter disorders using proton MR spectroscopic imaging. American Journal of Neuroradiology, 29(7), 1270-1275. https://doi.org/10.3174/ajnr.A1106

Classification of childhood white matter disorders using proton MR spectroscopic imaging. / Bizzi, Alberto; Castelli, G.; Bugiani, M.; Barker, P. B.; Herskovits, E. H.; Danesi, U.; Erbetta, A.; Moroni, I.; Farina, L.; Uziel, G.

In: American Journal of Neuroradiology, Vol. 29, No. 7, 08.2008, p. 1270-1275.

Research output: Contribution to journalArticle

Bizzi, Alberto ; Castelli, G. ; Bugiani, M. ; Barker, P. B. ; Herskovits, E. H. ; Danesi, U. ; Erbetta, A. ; Moroni, I. ; Farina, L. ; Uziel, G. / Classification of childhood white matter disorders using proton MR spectroscopic imaging. In: American Journal of Neuroradiology. 2008 ; Vol. 29, No. 7. pp. 1270-1275.
@article{e7ae2e0c54784b4d94eb82c245d07ebe,
title = "Classification of childhood white matter disorders using proton MR spectroscopic imaging",
abstract = "BACKGROUND AND PURPOSE: Childhood white matter disorders often show similar MR imaging signal-intensity changes, despite different underlying pathophysiologies. The purpose of this study was to determine if proton MR spectroscopic imaging (1H-MRSI) may help identify tissue pathophysiology in patients with leukoencephalopathies. MATERIALS AND METHODS: Seventy patients (mean age, 6; range, 0.66-17 years) were prospectively examined by 1H-MRSI; a diagnosis of leukoencephalopathy due to known genetic defects leading to lack of formation, breakdown of myelin, or loss of white matter tissue attenuation (rarefaction) was made in 47 patients. The diagnosis remained undefined (UL) in 23 patients. Patients with definite diagnoses were assigned (on the basis of known pathophysiology) to 3 groups corresponding to hypomyelination, white matter rarefaction, and demyelination. Choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) signals from 6 white matter regions and their intra- and intervoxel (relative to gray matter) ratios were measured. Analysis of variance was performed by diagnosis and by pathophysiology group. Stepwise linear discriminant analysis was performed to construct a model to predict pathophysiology on the basis of 1H-MRSI, and was applied to the UL group. RESULTS: Analysis of variance by diagnosis showed 3 main metabolic patterns. Analysis of variance by pathophysiology showed significant differences for Cho/NAA (P <.001), Cho/Cr (P <.004), and NAA/Cr (P <.002). Accuracy of the linear discriminant analysis model was 75{\%}, with Cho/Cr and NAA/Cr being the best parameters for classification. On the basis of the linear discriminant analysis model, 61{\%} of the subjects in the UL group were classified as hypomyelinating. CONCLUSION: 1H-MRSI provides information on tissue pathophysiology and may, therefore, be a valuable tool in the evaluation of patients with leukoencephalopathies.",
author = "Alberto Bizzi and G. Castelli and M. Bugiani and Barker, {P. B.} and Herskovits, {E. H.} and U. Danesi and A. Erbetta and I. Moroni and L. Farina and G. Uziel",
year = "2008",
month = "8",
doi = "10.3174/ajnr.A1106",
language = "English",
volume = "29",
pages = "1270--1275",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "7",

}

TY - JOUR

T1 - Classification of childhood white matter disorders using proton MR spectroscopic imaging

AU - Bizzi, Alberto

AU - Castelli, G.

AU - Bugiani, M.

AU - Barker, P. B.

AU - Herskovits, E. H.

AU - Danesi, U.

AU - Erbetta, A.

AU - Moroni, I.

AU - Farina, L.

AU - Uziel, G.

PY - 2008/8

Y1 - 2008/8

N2 - BACKGROUND AND PURPOSE: Childhood white matter disorders often show similar MR imaging signal-intensity changes, despite different underlying pathophysiologies. The purpose of this study was to determine if proton MR spectroscopic imaging (1H-MRSI) may help identify tissue pathophysiology in patients with leukoencephalopathies. MATERIALS AND METHODS: Seventy patients (mean age, 6; range, 0.66-17 years) were prospectively examined by 1H-MRSI; a diagnosis of leukoencephalopathy due to known genetic defects leading to lack of formation, breakdown of myelin, or loss of white matter tissue attenuation (rarefaction) was made in 47 patients. The diagnosis remained undefined (UL) in 23 patients. Patients with definite diagnoses were assigned (on the basis of known pathophysiology) to 3 groups corresponding to hypomyelination, white matter rarefaction, and demyelination. Choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) signals from 6 white matter regions and their intra- and intervoxel (relative to gray matter) ratios were measured. Analysis of variance was performed by diagnosis and by pathophysiology group. Stepwise linear discriminant analysis was performed to construct a model to predict pathophysiology on the basis of 1H-MRSI, and was applied to the UL group. RESULTS: Analysis of variance by diagnosis showed 3 main metabolic patterns. Analysis of variance by pathophysiology showed significant differences for Cho/NAA (P <.001), Cho/Cr (P <.004), and NAA/Cr (P <.002). Accuracy of the linear discriminant analysis model was 75%, with Cho/Cr and NAA/Cr being the best parameters for classification. On the basis of the linear discriminant analysis model, 61% of the subjects in the UL group were classified as hypomyelinating. CONCLUSION: 1H-MRSI provides information on tissue pathophysiology and may, therefore, be a valuable tool in the evaluation of patients with leukoencephalopathies.

AB - BACKGROUND AND PURPOSE: Childhood white matter disorders often show similar MR imaging signal-intensity changes, despite different underlying pathophysiologies. The purpose of this study was to determine if proton MR spectroscopic imaging (1H-MRSI) may help identify tissue pathophysiology in patients with leukoencephalopathies. MATERIALS AND METHODS: Seventy patients (mean age, 6; range, 0.66-17 years) were prospectively examined by 1H-MRSI; a diagnosis of leukoencephalopathy due to known genetic defects leading to lack of formation, breakdown of myelin, or loss of white matter tissue attenuation (rarefaction) was made in 47 patients. The diagnosis remained undefined (UL) in 23 patients. Patients with definite diagnoses were assigned (on the basis of known pathophysiology) to 3 groups corresponding to hypomyelination, white matter rarefaction, and demyelination. Choline (Cho), creatine (Cr), and N-acetylaspartate (NAA) signals from 6 white matter regions and their intra- and intervoxel (relative to gray matter) ratios were measured. Analysis of variance was performed by diagnosis and by pathophysiology group. Stepwise linear discriminant analysis was performed to construct a model to predict pathophysiology on the basis of 1H-MRSI, and was applied to the UL group. RESULTS: Analysis of variance by diagnosis showed 3 main metabolic patterns. Analysis of variance by pathophysiology showed significant differences for Cho/NAA (P <.001), Cho/Cr (P <.004), and NAA/Cr (P <.002). Accuracy of the linear discriminant analysis model was 75%, with Cho/Cr and NAA/Cr being the best parameters for classification. On the basis of the linear discriminant analysis model, 61% of the subjects in the UL group were classified as hypomyelinating. CONCLUSION: 1H-MRSI provides information on tissue pathophysiology and may, therefore, be a valuable tool in the evaluation of patients with leukoencephalopathies.

UR - http://www.scopus.com/inward/record.url?scp=49749135519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49749135519&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A1106

DO - 10.3174/ajnr.A1106

M3 - Article

VL - 29

SP - 1270

EP - 1275

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 7

ER -